Orthopedic implant manufacturer Wishbone Medical has strengthened its portfolio with the acquisition of two spine device companies — Back 2 Basics Direct and Orbbö Surgical.
The two companies focus on research, development and commercialization of sterile packaged implants and surgical tools for spinal fusion.
Back 2 Basics Direct and Orbbö Surgical represent Wishbone Medical's fifth and sixth acquisitions in the past 18 months, according to an Aug. 5 announcement.
The acquisitions add nine FDA-cleared spinal fusion products to Wishbone Medical's portfolio, which is expected to bring more than $12 million in year one revenue for the company.
Twenty spine-focused employees will be added to Wishbone Medical's global team of 165.